GLAUKOS Corp
GKOS- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001192448
In the last 90 days, GLAUKOS Corp insiders filed 0 open-market purchases and 7 sales; 368 institutions reported holding it in 13F filings for Q2 2026, worth $8.44B in total; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 29, 2026, 1:13 AM ET
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025! | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 13, 2026 | Feb 20, 2025 | Jan 9, 2024 | Feb 22, 2023 | Feb 22, 2022 |
| Revenue | $507.4M | $383.5M | $314.7M | $282.9M | $294.0M |
| Cost of revenue | $111.8M | $94.0M | $75.6M | $69.0M | $66.6M |
| Gross profit | $282.8M | $289.5M | $239.1M | $213.9M | $227.4M |
| Operating expenses | $482.4M | $411.8M | $367.8M | $296.2M | $260.3M |
| Research and development | $150.6M | $136.4M | $138.8M | $123.3M | $101.0M |
| Selling, general and administrative | $331.7M | $261.2M | $224.1M | $192.9M | $179.3M |
| Operating income | -$199.6M | -$122.4M | -$128.7M | -$82.3M | -$32.9M |
| Interest expense | – | – | $13.6M | $13.7M | $13.4M |
| Income tax | -$5.35M | $771.0K | $934.0K | $766.0K | $326.0K |
| Net income | -$187.7M | -$146.4M | -$134.7M | -$99.2M | -$49.6M |
| EPS, basic | $-3.28 | $-2.77 | $-2.78 | $-2.09 | $-1.07 |
| EPS, diluted | $-3.28 | $-2.77 | $-2.78 | $-2.09 | $-1.07 |
| Weighted shares, basic | 57.2M | 52.8M | 48.4M | 47.4M | 46.4M |
| Weighted shares, diluted | 57.2M | 52.8M | 48.4M | 47.4M | 46.4M |
| Margins and growth | |||||
| Gross margin | 55.7% | 75.5% | 76.0% | 75.6% | 77.3% |
| Operating margin | -39.3% | -31.9% | -40.9% | -29.1% | -11.2% |
| Net margin | -37.0% | -38.2% | -42.8% | -35.1% | -16.9% |
| Revenue growth, year over year | +32.3% | +21.9% | +11.3% | −3.8% | +30.7% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 13, 2026 | Feb 20, 2025 | Jan 9, 2024 | Feb 22, 2023 | Feb 22, 2022 |
| Cash and equivalents | $90.8M | $169.6M | $93.5M | $119.5M | $100.7M |
| Accounts receivable | $108.6M | $60.7M | $39.9M | $36.1M | $33.4M |
| Inventory | $63.6M | $57.7M | $42.0M | $37.8M | $23.0M |
| Total current assets | $475.0M | $449.8M | $395.5M | $443.9M | $486.1M |
| Property, plant and equipment | $113.3M | $97.9M | $103.2M | $94.4M | $69.0M |
| Goodwill | $66.7M | $66.1M | $66.1M | $66.1M | $66.1M |
| Intangible assets | $141.9M | $263.4M | $283.0M | $307.9M | $332.8M |
| Total assets | $893.5M | $974.8M | $940.4M | $1.00B | $1.05B |
| Accounts payable | $24.6M | $13.0M | $13.4M | $14.4M | $7.33M |
| Total current liabilities | $101.3M | $75.1M | $74.0M | $72.4M | $63.4M |
| Total liabilities | $237.3M | $207.8M | $478.6M | $472.4M | $462.5M |
| Shareholders' equity | $656.2M | $766.9M | $461.8M | $530.0M | $587.2M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 13, 2026 | Feb 20, 2025 | Jan 9, 2024 | Feb 22, 2023 | Feb 22, 2022 |
| Operating cash flow | -$14.8M | -$61.3M | -$57.8M | -$33.1M | $24.7M |
| Capital expenditures | $7.67M | $6.30M | $20.2M | $30.3M | $47.8M |
| Free cash flow | -$22.5M | -$67.6M | -$78.0M | -$63.3M | -$23.1M |
| Depreciation and amortization | $38.1M | $35.6M | $33.7M | $31.6M | $29.7M |
| Stock-based compensation | $63.2M | $50.2M | $43.5M | $38.6M | $30.1M |
| Investing cash flow | -$77.6M | $47.8M | $14.1M | $44.8M | -$58.2M |
| Financing cash flow | $11.9M | $91.5M | $15.0M | $6.25M | $39.3M |
| Net change in cash | -$79.7M | $75.0M | -$27.3M | $16.5M | $3.96M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 12.5% | 13.1% | 13.8% | 13.6% | 10.3% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Oct 26, 2026 | 59.2M | +3.1% | SEC |
| Jul 28, 2026 | 59.0M | +2.8% | SEC |
| Apr 28, 2026 | 58.7M | +2.8% | SEC |
| Feb 18, 2026 | 58.1M | +2.7% | SEC |
| Oct 29, 2025 | 57.4M | +4.2% | SEC |
| Jul 31, 2025 | 57.3M | +4.4% | SEC |
| Apr 29, 2025 | 57.1M | +13.4% | SEC |
| Feb 19, 2025 | 56.6M | +14.3% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
- A column marked ! failed an accounting identity (gross profit = revenue − cost of revenue, or assets = liabilities + equity, within 1%). Its numbers are shown as filed.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.